Gettysburg College

Carisma Therapeutics Announces Changes to its Board of Directors

Retrieved on: 
Monday, April 1, 2024
Internal medicine, Novartis, Biomedicine, Torque, Oncology, Patient, University, Audit committee, Senior, Dentistry, GSK plc, Chemistry, CARM, Therapy, Drug development, Gettysburg College, Pharmaceutical industry

PHILADELPHIA, April 1, 2024 /PRNewswire/ -- Carisma Therapeutics Inc. (Nasdaq: CARM) ("Carisma" or the "Company"), a clinical-stage biopharmaceutical company focused on discovering and developing innovative immunotherapies, today announced the appointment of John Hohneker, M.D. to the Board of Directors of the Company, effective April 1, 2024. Additionally, the Company announced that Chidozie Ugwumba, who has served on Carisma's Board of Directors since December 2020, has advised the Board of his intent to step down from his role as a member of the Board and chair of the Audit Committee of the Board effective April 1, 2024, as a result of his other professional commitments. 

Key Points: 
  • to the Board of Directors of the Company, effective April 1, 2024.
  • "We are pleased to welcome John to the Carisma Board of Directors," said Sanford Zweifach, Chair of the Carisma Board of Directors.
  • "I am excited to join Carisma's Board as the Company continues to develop innovative immunotherapies," said Dr. Hohneker.
  • Dr. Hohneker currently serves on the Board of Directors of Curis, Inc., Sonata Therapeutics, Inc., and Trishula Therapeutics, Inc.

OCLI Vision Welcomes Dr. Kinnari Patel, OD, to the Northeast Philadelphia, Pennsylvania Area to Expand Access to Great Eye Care in the Region

Retrieved on: 
Monday, February 5, 2024
Gettysburg College, Knowledge, University, Glaucoma, AMD, OD, Patient, Central Florida, Health, Optometry, Macular degeneration, Telecanthus, Diabetic retinopathy, Telescopic sight

GARDEN CITY, N.Y., Feb. 5, 2024 /PRNewswire-PRWeb/ -- OCLI Vision is thrilled to announce the latest addition to our team, Dr. Kinnari Patel, OD, who will be exclusively serving the Northeast Philadelphia location starting February 5th, 2024.

Key Points: 
  • Dr. Patel, a highly accomplished optometrist, brings over a decade of experience and expertise in primary eye care.
  • "I am delighted to join OCLI Vision team, where I can leverage my decade-long experience to provide outstanding eye care to patients.
  • I provide patient care for all aspects of primary eye care with focus on Dry Eye and Ocular Surface Disease."
  • I provide patient care for all aspects of primary eye care with focus on Dry Eye and Ocular Surface Disease.

SightMD New York Welcomes Clearview Eye Surgery to It's Expert Team

Retrieved on: 
Thursday, January 25, 2024
Family, Patient, Cataract, United States Army, Blepharoplasty, Health, Contact, Trust, Stony Brook University, Partnership, Retina, Eye, Retinal, Communication, Diabetic retinopathy, PHD, Macular degeneration, Strabismus, Suite, Acquisition, Bachelor of Science, Glaucoma, DSM-IV codes, OD, Gettysburg College, Diagnosis, Physician

HAUPPAUGE, N.Y., Jan. 25, 2024 /PRNewswire-PRWeb/ -- SightMD New York, a leading multi-specialty ophthalmology platform, announced a strategic partnership with Clearview Eye Surgery. Through this strategic partnership Clearview's practice locations at 1825 Riverside Drive, Suite 1B New York, NY 10034, 1200 Waters Place, Suite 304 Bronx, NY 10461 and 132-15 41st Avenue CC Flushing , NY 11355 will expand SightMD's presence by adding three locations and five providers, growing SightMD's current footprint to 40+ locations and 85+ providers across New York.

Key Points: 
  • HAUPPAUGE, N.Y., Jan. 25, 2024 /PRNewswire-PRWeb/ -- SightMD New York, a leading multi-specialty ophthalmology platform, announced a strategic partnership with Clearview Eye Surgery.
  • - Dr. John J. Kim, Founder of Clearview Eye Surgery
    "We are excited to welcome Clearview Eye Surgery into the SightMD family.
  • Clearview Eye Surgery is dedicated to providing state of the art, professional and personalized eye care to all of our patients to ensure the best possible outcome.
  • Thousands of people have trusted their award-winning team with their families' eye care and vision correction treatment, and we are grateful for the opportunity to have them join the expert team at SightMD.

Saint Joseph's University and Pennsylvania College of Health Sciences Complete Landmark Merger, Bolstering Healthcare Education Offerings

Retrieved on: 
Friday, January 12, 2024
Student, Patient, Outline of health sciences, CNE, BSN, Science, Hawk Hill, Multimedia, NCLEX, Partnership, Faculty, Curriculum, University, University of the Sciences, Saint Joseph's University, Acquisition, Caregiver, Doctor of Philosophy, Organization, FNP, Nursing, Gettysburg College

PHILADELPHIA and LANCASTER, Pa., Jan. 12, 2024 /PRNewswire/ -- Saint Joseph's University completed a landmark merger with Pennsylvania College of Health Sciences (PA College), resulting in the acquisition of more than 15 new nursing and allied health programs. The acquisition, which follows closely on the heels of another successful merger with University of the Sciences, further expands Saint Joseph's academic portfolio in the health sciences in the broader region and brings a bachelor's level nursing program to the University's Philadelphia location.

Key Points: 
  • "This merger not only continues PA College's legacy of excellence in healthcare education in the Lancaster community, but also allows Saint Joseph's to continue expanding our offerings in sought-after nursing and healthcare programs," said Cheryl A. McConnell, PhD , president of Saint Joseph's.
  • Both Saint Joseph's University and the Pennsylvania College of Health Sciences are dedicated to educational excellence and share a passion for advancing healthcare.
  • In addition to the merger agreement, Saint Joseph's has penned two additional agreements: one with Lancaster General Health and one with Penn Medicine.
  • Additionally, the University of Pennsylvania Health System (Penn Medicine) will reserve clinical placements in the Philadelphia metropolitan area for Saint Joseph's Hawk Hill nursing students.

SOUNDCLOUD NAMES TOM SANSONE AS CHIEF FINANCIAL OFFICER/CHIEF OPERATING OFFICER

Retrieved on: 
Tuesday, January 9, 2024
McDonough School of Business, Music, PwC, CFO, Kobalt Music Group, Business, Georgetown University, Accounting, Trustee, Sale, Gettysburg College, SoundCloud

NEW YORK, Jan. 9, 2024 /PRNewswire/ -- Tom Sansone has been named CFO/COO by SoundCloud effective immediately, it was announced today by Eliah Seton, Chief Executive Officer.

Key Points: 
  • NEW YORK, Jan. 9, 2024 /PRNewswire/ -- Tom Sansone has been named CFO/COO by SoundCloud effective immediately, it was announced today by Eliah Seton, Chief Executive Officer.
  • Sansone brings more than 20 years of global financial and operational excellence in the technology and music industries and a track record of leading business transformation.
  • In his new role, Sansone will help drive the execution of SoundCloud's strategic roadmap through operational rigor, corporate development, M&A, financial performance and capital structuring.
  • "On behalf of the Board of Directors and management of SoundCloud, I want to welcome Tom to the team.

Calliditas announces additions to the management team

Retrieved on: 
Friday, December 1, 2023
Transfer, Indivior, New product development, Corporation, Sustainability, General counsel, AstraZeneca, Quality assurance, CALT, Pharmacy, CET, Allan Nyom, University, Endo International, Person, CMC, Doctor of Philosophy, Gettysburg College, Management, Pfizer

STOCKHOLM, Dec. 1, 2023 /PRNewswire/ -- Calliditas Therapeutics AB (Nasdaq: CALT) (Nasdaq Stockholm: CALTX) ('Calliditas') today announced that the company has added a new member to its management team, Head of Technical Operations Lars Stubberud.

Key Points: 
  • STOCKHOLM, Dec. 1, 2023 /PRNewswire/ -- Calliditas Therapeutics AB (Nasdaq: CALT) (Nasdaq Stockholm: CALTX) ('Calliditas') today announced that the company has added a new member to its management team, Head of Technical Operations Lars Stubberud.
  • Brian Gorman is an accomplished legal and business executive with more than 20 years of experience advising corporate boards and executive management teams of life science companies.
  • He joins Calliditas after having served most recently as Executive Vice President, Corporate Development & General Counsel at Opiant Pharmaceuticals, which was acquired by Indivior PLC.
  • We welcome Brian to the team and look forward to working with him as we embark on the next chapter of our journey," said Renée Aguiar-Lucander, CEO Calliditas.

Calliditas announces additions to the management team

Retrieved on: 
Friday, December 1, 2023
Transfer, Indivior, New product development, Corporation, Sustainability, General counsel, AstraZeneca, Quality assurance, CALT, Pharmacy, CET, Allan Nyom, University, Endo International, Person, CMC, Doctor of Philosophy, Gettysburg College, Management, Pfizer

STOCKHOLM, Dec. 1, 2023 /PRNewswire/ -- Calliditas Therapeutics AB (Nasdaq: CALT) (Nasdaq Stockholm: CALTX) ('Calliditas') today announced that the company has added a new member to its management team, Head of Technical Operations Lars Stubberud.

Key Points: 
  • STOCKHOLM, Dec. 1, 2023 /PRNewswire/ -- Calliditas Therapeutics AB (Nasdaq: CALT) (Nasdaq Stockholm: CALTX) ('Calliditas') today announced that the company has added a new member to its management team, Head of Technical Operations Lars Stubberud.
  • Brian Gorman is an accomplished legal and business executive with more than 20 years of experience advising corporate boards and executive management teams of life science companies.
  • He joins Calliditas after having served most recently as Executive Vice President, Corporate Development & General Counsel at Opiant Pharmaceuticals, which was acquired by Indivior PLC.
  • We welcome Brian to the team and look forward to working with him as we embark on the next chapter of our journey," said Renée Aguiar-Lucander, CEO Calliditas.

Delta College Enhances Flexibility and Diversity of Mental Health Support

Retrieved on: 
Wednesday, November 29, 2023
Senior counsel, Delta College, University of Michigan, Mental health, Sheridan College, Student, Student Success Act, Michigan State University, Delta, Environment, University, Gettysburg College, Partnership, Nursing

NATICK, Mass., Nov. 29, 2023 /PRNewswire/ -- Delta College, today, announced a partnership with Uwill, the leading mental health and wellness solution for colleges and students, to enhance and expand the college's existing counseling capabilities. Delta brings in Uwill to supplement existing campus resources and to address the increased mental health support and crisis needs. Uwill's proprietary technology facilitates immediate appointments with licensed mental health counselors based on student needs and preferences.

Key Points: 
  • Delta brings in Uwill to supplement existing campus resources and to address the increased mental health support and crisis needs.
  • Uwill's proprietary technology facilitates immediate appointments with licensed mental health counselors based on student needs and preferences.
  • "We believe that prioritizing mental health is vital in creating an environment where students can flourish academically, personally, and professionally," said Shelly Raube, Dean of Student Success at Delta College.
  • Uwill partners with students from all 50 states at institutions including Michigan State University, Sheridan College, Gettysburg College, and University of Michigan.

Cheryl A. McConnell, PhD, Inaugurated as 29th President of Saint Joseph's University

Retrieved on: 
Friday, September 8, 2023
University of the Sciences, Society, Cheryl, University, Education, Friends, Spirituality, Holy Spirit, Teaching, MBA, Multimedia, Gettysburg College, Saint Joseph's, Doctor of Philosophy, Arena, Science, Cheryl B. Schrader, St. Joseph's Preparatory School, Student, Acquisition, Publication, SJU, Local, Mass, Cornell University Board of Trustees, Love, McConnell, Saint Joseph, Outline of health sciences, Faculty, Roman Catholic Archdiocese of Philadelphia, Growth, Health, Ignatius of Loyola, Female, Pennsylvania College of Health Sciences, Nursing, Management, Jesuits, Trustee

PHILADELPHIA, Sept. 8, 2023 On Friday, Saint Joseph's University inaugurated Cheryl A. McConnell, PhD , as the 29th — and first female — president in the University's 172-year history.

Key Points: 
  • PHILADELPHIA, Sept. 8, 2023 On Friday, Saint Joseph's University inaugurated Cheryl A. McConnell, PhD , as the 29th — and first female — president in the University's 172-year history.
  • Cheryl is a first-generation college graduate who has immersed herself in the twin Jesuit traditions of spirituality and of service."
  • The Mass, which is a ceremonial start of the school year, was also the inaugural Mass for President McConnell.
  • As interim president, she finalized another merger agreement with the Pennsylvania College of Health Sciences , expected to close in January 2024.

Schulte Roth & Zabel Bolsters M&A and Securities Group With Addition of David Curtiss

Retrieved on: 
Wednesday, September 6, 2023
Consulting, Professional Services, Legal, SPAC, Science, Daiwa Securities Group, Gettysburg College, PIPE, Washington College of Law, Special, Roth, Title 11 of the United States Code, Investment, Shareholder, Security (finance), Schulte Roth & Zabel, Private investigator, Financial services

Schulte Roth & Zabel is proud to announce the addition of David Curtiss as a partner in the M&A and Securities Group in New York.

Key Points: 
  • Schulte Roth & Zabel is proud to announce the addition of David Curtiss as a partner in the M&A and Securities Group in New York.
  • “David will have an immediate impact on our securities capabilities, including in PIPEs, converts and 144A transactions, as well as across our Investment Management, Shareholder Activism, M&A and Business Reorganization practices.
  • We’re very excited for him to join the team,” said Ele Klein, co-chair of the M&A and Securities and Shareholder Activism groups.
  • “David has a high level of sophisticated experience that will be a great benefit to a wide range of our private capital clients,” said David Efron, Schulte’s co-managing partner.